Stephen Hauser

Credentials: · · · · · ·

History

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
New England Journal of Medicine · 2008 · First of 13 authors · Corresponding · 1,936 citations
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
New England Journal of Medicine · 2017 · First of 22 authors · 1,531 citations
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
New England Journal of Medicine · 2017 · 1,412 citations

The Role of B Cells in the Origin and Progression of Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · R35
Contact PI · $9.1M · University of California, San Francisco
2019–2027
NINDS Research Education Programs for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (R25)
National Institute of Neurological Disorders and Stroke · R25
Contact PI · $3M · University of California, San Francisco
2010–2020
Disease Relevance of CD20 Expression on T Cells in Multiple Sclerosis Patients
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.7M · University of California, San Francisco
2015–2020
Gene Linkage Study of Multiple Sclerosis Sibling Pairs
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $9.6M · University of California, San Francisco
1988–2019